Sign inJoin waitlistJoin the waitlist

MF

Michael Farkouh

Cardiovascular Disease

Credentials: · · · · ·

History

Cardiovascular Disease
1991–1994
Internal Medicine
1988–1991
Doctor of Medicine
1984–1988

Research

Strategies for multivessel revascularization in patients with diabetes
New England Journal of Medicine · 2012 · First of 29 authors · 1,452 citations
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
Systematic review or meta-analysis · The Lancet · 2013 · 1,268 citations
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
New England Journal of Medicine · 2021 · 780 citations

Valentin Fuster
73 papers
JU
Jacob Udell
40 papers
Robert Rosenson
36 papers
SB
Sameer Bansilal
26 papers · 23 as a resident
PL
Patrick Lawler
24 papers
Vera Bittner
24 papers
GS
Gregg Stone
22 papers
VM
Verghese Mathew
22 papers
Michael Domanski
20 papers
Charanjit Rihal
19 papers · 1 as a fellow
Monika Safford
19 papers
Naveen Pereira
19 papers

Grants

Clinical Implementation of Clopidogrel Pharmacogenetics: The TAILOR-PCI Trial - CCC - Lead Application
National Heart, Lung, and Blood Institute · U01
PI · $6.1M · Mayo Clinic Rochester
2016–2021
Novel Imaging to Predict Cardiovascular Events in Diabetes
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · Icahn School of Medicine at Mount Sinai
2009–2013

Clinical trials

The Açaí Berry COVID-19 Anti-Inflammation Trial
Principal investigator · Unknown · Phase 2
University Health Network, Toronto
2020–2022
Eliminate Coronary Artery Disease
Principal investigator · Terminated · Phase 2
University Health Network, Toronto
2014–2019
Tailored Antiplatelet Therapy Following PCI
Principal investigator · Completed · Phase 4
Mayo Clinic
2013–2020